Raanan Berger

専門分野: Radiation oncologist
27年の経験
話します:
English, Hebrew, Russian
オンラインコンサルテーション：利用可能
勤務先: イスラエル, ラマト・ガン, シェバ医療センター
Included in Forbes Israel’s “Best Doctors” list (2025).
Dr. Raanan Berger is the Director of the Cancer Center at Sheba Medical Center. He was listed in Forbes Israel’s “Best Doctors” in 2025. Dr. Berger specializes in genitourinary oncology and radiates complex prostate tumors. He completed a postdoctoral fellowship at the Dana-Farber/Harvard Cancer Institute.
- Heads the clinical research unit focusing on molecular oncology.
- Co-authored over 20 peer-reviewed papers on prostate cancer and BRCA mutations.
- Member of the American Society of Clinical Oncology (ASCO).
- Performs systemic therapy and radiotherapy at a Top-10 globally ranked hospital.

Raanan Bergerとのオンラインコンサルテーション

便利で簡単

100%安全で機密

$650

調子はいかがですか？

1 の 3

この医師の情報は完全で明確です

強く反対

強く賛成

資格

Prof. Raanan Berger is a medical oncologist and radiotherapist at Sheba Medical Center. He serves as the Director of the Cancer Center and heads the clinical research unit. Prof. Berger was recognized in the 2025 Forbes Israel’s “Best Doctors” list.

Oncology Specialization and Approach

Prof. Berger leads the genitourinary oncology program with a primary focus on prostate cancer. He integrates systemic therapy and radiotherapy into a multidisciplinary care model. This approach combines medical treatment with psychological and social support for families. This lets patients receive emotional guidance throughout the process.

The doctor also treats a translational research laboratory. He investigates the molecular mechanisms that drive prostate and breast cancer development. His clinical work includes personalized treatment plans using neuroendoscopic methods for various genitourinary cancers. This work helps identify new ways to treat cancer.

Research and Scientific Contributions

Prof. Berger has co-authored over 20 peer-reviewed scientific publications. His research highlights include:

Classification studies of high-risk versus very high-risk prostate cancer
Outcomes of radiotherapy combined with androgen deprivation therapy
Research on inherited BRCA1 and BRCA2 mutations in large international cohorts
Study of molecular oncology and tumorigenesis mechanisms

Professional Experience

Director of the Cancer Center, Sheba Medical Center
Head of the Clinical Research Unit, Institute of Oncology and Radiotherapy
Lead of the Genitourinary Oncology Program, Sheba Medical Center

Education and Training

MD and PhD – School of Medicine, Tel Aviv University, Israel
Clinical training in Medical Oncology and Radiotherapy – Sheba Medical Center
Postdoctoral fellowship – Dana-Farber Cancer Institute, Harvard Medical School

During his Harvard fellowship, he focused on prostate cancer treatment with Dr. Philip Kantoff. He also conducted molecular oncology research in the laboratory of Dr. William C. Hahn. This research investigates the genetic causes of tumor growth.